Clarus Therapeutics Holdings Total Current Liabilities

As of the most recent data (June 2022), CRXT shows a total current liabilities of $62M. That compares with $77M in the prior-year period — down 19.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRXT's total current liabilities is now $62M (was $77M) — a 19.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Clarus Therapeutics Holdings is outperforming or lagging.

Tracking CRXT's total current liabilities over time shows whether Clarus Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $62M That compares with $77M in the prior-year period — down 19.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Clarus Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $62M) with ownership activity and broader fundamentals.